TransEnterix Inc. [AMEX: TRXC] surged by $0.46 during the normal trading session on Friday and reaching a high of $6.58 during the day while it closed the day at $6.25. The company report on February 11, 2021 that Global Cardiovascular Devices Market Now Project to Exceed $71 Billion By 2027.
Financialnewsmedia.com News Commentary.
Cardiovascular devices are the medical devices which are used to diagnosis and treat the heart diseases and other heart-related problems. These devices play essential role prevention and treatment of cardiovascular diseases. The cardiovascular devices include implantable cardioverter defibrillators, implanted heart rhythm monitors, pacemakers, and various other devices. The cardiovascular devices market is currently witnessing considerable demand across the globe. Increasing awareness about the various cardiovascular diseases and increasing geriatric population across the world are the primary factors driving the growth of the market. As per the estimation of the World Health Organization (WHO), cardiovascular diseases are the number one cause for death globally and taking around 17.9 million lives every year. Thus, the rising prevalence of cardiovascular diseases is one of the key factors fueling the growth of the market. A report by FiorMarkets projected that the global cardiovascular devices market is expected to grow from USD 42.61 billion in 2019 to USD 71.05 billion by 2027, at a CAGR of 6.6% during the forecast period 2020-2027. Active healthcare and tech stocks in news include: BioSig Technologies, Inc. (NASDAQ: BSGM), Medtronic plc (NYSE: MDT), Boston Scientific Corporation (NYSE: BSX), TransEnterix, Inc. (NYSE: TRXC), PAVmed Inc. (NASDAQ: PAVM).
TransEnterix Inc. stock has also gained 75.56% of its value over the past 7 days. However, TRXC stock has inclined by 1431.49% in the 3 months of the year. Over the past six months meanwhile, it has gained 1377.19% and gained 900.00% year-on date.
The market cap for TRXC stock reached $806.63 million, with 176.00 million shares outstanding and 97.63 million shares in the current float. Compared to the average trading volume of 27.03M shares, TRXC reached a trading volume of 23229908 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about TransEnterix Inc. [TRXC]:
Ladenburg Thalmann have made an estimate for TransEnterix Inc. shares, keeping their opinion on the stock as Neutral, with their previous recommendation back on January 20, 2021. While these analysts kept the previous recommendation, RBC Capital Mkts dropped their target price from $3 to $1. The new note on the price target was released on August 08, 2019, representing the official price target for TransEnterix Inc. stock. Previously, the target price had yet another raise to $1.60, while Piper Jaffray analysts kept a Neutral rating on TRXC stock.
The Average True Range (ATR) for TransEnterix Inc. is set at 0.81, with the Price to Sales ratio for TRXC stock in the period of the last 12 months amounting to 288.08. The Price to Book ratio for the last quarter was 9.77.
TRXC stock trade performance evaluation
TransEnterix Inc. [TRXC] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 75.56. With this latest performance, TRXC shares gained by 259.20% in over the last four-week period, additionally plugging by 1377.19% over the last 6 months – not to mention a rise of 404.03% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for TRXC stock in for the last two-week period is set at 78.45, with the RSI for the last a single of trading hit 79.30, and the three-weeks RSI is set at 77.94 for TransEnterix Inc. [TRXC]. The present Moving Average for the last 50 days of trading for this stock 2.00, while it was recorded at 5.43 for the last single week of trading, and 0.82 for the last 200 days.
TransEnterix Inc. [TRXC]: An insightful look at the core fundamentals
Operating Margin for any stock indicates how profitable investing would be, and TransEnterix Inc. [TRXC] shares currently have an operating margin of -1075.38 and a Gross Margin at -263.76. TransEnterix Inc.’s Net Margin is presently recorded at -1807.54.
Return on Total Capital for TRXC is now -71.81, given the latest momentum, and Return on Invested Capital for the company is -121.23. Return on Equity for this stock declined to -137.65, with Return on Assets sitting at -95.03. When it comes to the capital structure of this company, TransEnterix Inc. [TRXC] has a Total Debt to Total Equity ratio set at 4.52. Additionally, TRXC Total Debt to Total Capital is recorded at 4.33, with Total Debt to Total Assets ending up at 3.12. Long-Term Debt to Equity for the company is recorded at 2.52, with the Long-Term Debt to Total Capital now at 2.41.
Reflecting on the efficiency of the workforce at the company, TransEnterix Inc. [TRXC] managed to generate an average of -$946,018 per employee. Receivables Turnover for the company is 1.43 with a Total Asset Turnover recorded at a value of 0.05.TransEnterix Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 2.30 and a Current Ratio set at 3.20.
Earnings per share (EPS) analysis for TransEnterix Inc. [TRXC] stock
With the latest financial reports released by the company, TransEnterix Inc. posted -0.83/share EPS, while the average EPS was predicted by analysts to be reported at -0.62/share. When compared, the two values demonstrate that the company fail the estimates by a Surprise Factor of -33.90%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for TRXC.
TransEnterix Inc. [TRXC]: Insider Ownership positions
There are presently around $54 million, or 21.30% of TRXC stock, in the hands of institutional investors. The top three institutional holders of TRXC stocks are: VANGUARD GROUP INC with ownership of 2,158,994, which is approximately 18.255% of the company’s market cap and around 0.30% of the total institutional ownership; RENAISSANCE TECHNOLOGIES LLC, holding 1,427,000 shares of the stock with an approximate value of $8.92 million in TRXC stocks shares; and MASTERS CAPITAL MANAGEMENT LLC, currently with $5.62 million in TRXC stock with ownership of nearly 0% of the company’s market capitalization.
Positions in TransEnterix Inc. stocks held by institutional investors increased at the end of March and at the time of the March reporting period, where 18 institutional holders increased their position in TransEnterix Inc. [AMEX:TRXC] by around 1,598,225 shares. Additionally, 32 investors decreased positions by around 1,603,956 shares, while 30 investors held positions by with 5,438,444 shares. The mentioned changes placed institutional holdings at 8,640,625 shares, according to the latest SEC report filing. TRXC stock had 6 new institutional investments in for a total of 375,751 shares, while 18 institutional investors sold positions of 569,335 shares during the same period.